Heart Foundation

0025Reducing Gaps in Cardiovascular Risk Factor Awareness through Free At-Home LDL-C and Lipoprotein(a) Screening and Support: Insights from the First 30,950 Tests Ordered through the Family Heart Foundation Cholesterol Connect® Program

Background LDL cholesterol (LDL-C) and lipoprotein(a) (Lp(a)) are independent risk factors for cardiovascular disease (CVD). LDL-C and Lp(a) healthcare screening is inconsistent, leaving many Americans at risk. The Family Heart Foundation® launched the Cholesterol Connect® progra...

Effectiveness of Nurse-Coordinated, Digital-Supported Collaborative Care Model in Reducing Hospital Stay and Mortality Among Patients With Heart Failure: TIME-HF Cluster RCT India

BACKGROUND: Heart failure with reduced ejection fraction causes high mortality and recurrent hospitalizations in India. We evaluated the effectiveness of the collaborative care model in improving days alive and out of the hospital and overall survival. METHODS: We conducted a par...

Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event

BackgroundPatients are at increased risk for recurrent ischemic events after an acute coronary syndrome event. Milvexian, an oral factor XIa inhibitor, may reduce the risk of major adverse clinical events with minimal bleeding risk. MethodsIn this phase 3, randomized, placebo-con...

What a Vow Must Cost: Vow-Validity Conditions as an Alignment Eligibility Predicate

The Buddhavaṃsa's Two-Phase Test for a Binding Renunciation, Irreversibility as the Separating Condition, and Why an Alignment Commitment Becomes More Informative Exactly Where Behavioural Compliance Becomes Less Contemporary AI governance instruments are written in the grammar o...